Modification of vitamin B6 on the associations of blood lead levels and cardiovascular diseases in the US adults
Background Cardiovascular disease (CVD) is a leading cause of death in the US population. Lead exposure is an important risk factor of CVDs, as is associated with elevated homocysteine level and oxidative stress. We aim to examine whether vitamin B6, which has been shown to reduce homocysteine level...
Main Authors: | John S Ji, Jia Wei |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
|
Series: | BMJ Nutrition, Prevention & Health |
Online Access: | https://nutrition.bmj.com/content/early/2020/08/12/bmjnph-2020-000088.full |
Similar Items
-
Cardiovascular-Related Outcomes in U.S. Adults Exposed to Lead
by: Emmanuel Obeng-Gyasi, et al.
Published: (2018-04-01) -
The association between blood lead levels and cardiovascular diseases among lead-exposed male workers
by: Young-Sun Min, et al.
Published: (2017-07-01) -
Effect of varying levels of vitamin B-6 intake on lymphocyte mitogenic response and vitamin B-6 concentration in human peripheral blood mononuclear cells
by: Kwak, Ho-Kyung
Published: (2012) -
Vitamin B6 in Health and Disease
by: Kamilla Stach, et al.
Published: (2021-09-01) -
Role of N6-Methyladenosine RNA Modification in Cardiovascular Disease
by: Dandan Song, et al.
Published: (2021-05-01)